Global Health Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 19, 2025
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Global Health Limited (Medanta) has notified the 21st Annual General Meeting (AGM) to be held on Friday, September 19, 2025, at 12:00 noon via video conferencing. Key items include adoption of FY2024-25 financial statements and a final dividend of ₹0.50 per equity share (face value ₹2) with record date of August 22, 2025. The notice seeks shareholder approval to re-appoint Dr. Naresh Trehan as Chairman & Managing Director and as Chairman – Heart Institute & Chief Cardiac Surgeon for five years from August 1, 2026, with aggregate remuneration that could reach ₹48.50 crore by FY2030-31 (up from roughly ₹29.83 crore in FY2025-26). Other resolutions cover re-appointment of Independent Directors Vikram Singh Mehta and Hari Shanker Bhartia, ratification of Ravi Kant Jaipuria's rotation, ₹11.50 lakh fee for cost auditors Ramanath Iyer & Co., and appointment of MAKS & Co. as secretarial auditor for five years from April 1, 2025. Remote e-voting window is September 15–18, 2025.
Routine AGM notice with a modest final dividend; the headline item is the five-year re-appointment of founder Dr. Naresh Trehan at significantly higher remuneration (up to ~₹48.5 crore by FY31), which shareholders will vote on and which could be a point of discussion given the steep escalation.